Company Performance Metrics
- David Ufheil: Chief Financial Officer
- Roger Barrett: Founder and VP Operations
EPIEN Medical develops novel cleansers capable of removing biofilm on contact. HYBENX Desiccation Shock Debridement Technology (“DSD”) is a breakthrough treatment for infected tissue surfaces. These products, by definition, are not antibiotics. DSD is the basis for a unique new class of products that completely eradicate biofilm from infected
tissue surfaces. DSD provides an intense cleaning action that automatically differentiates between infected and underlying healthy tissues. Complete removal of biofilm has been confirmed using DNA and immunochemistry analysis techniques. The mechanism of this desiccation-based cleaning process is universal, physical, and non-biological.